CRONOS GROUP INC. Net Income (Loss) Attributable to Noncontrolling Interest
CRONOS GROUP INC. (CRON) reported Net Income (Loss) Attributable to Noncontrolling Interest of $3.58 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Net Income
us-gaap:NetIncomeLossAttributableToNoncontrollingInterest · last filed 2026-08-06
- CRONOS GROUP INC. net income (loss) attributable to noncontrolling interest for the quarter ending 2026-06-30 was $3.58M, a 191.13% increase year-over-year.
- CRONOS GROUP INC. net income (loss) attributable to noncontrolling interest for the quarter ending 2026-03-31 was $1.96M, a 22.36% increase year-over-year.
- CRONOS GROUP INC. net income (loss) attributable to noncontrolling interest for the quarter ending 2025-12-31 was $1.32M, a 525.00% increase year-over-year.
- CRONOS GROUP INC. net income (loss) attributable to noncontrolling interest for the quarter ending 2025-09-30 was $2.36M.
- CRONOS GROUP INC. net income (loss) attributable to noncontrolling interest for fiscal 2025 was $6.52M.
- CRONOS GROUP INC. net income (loss) attributable to noncontrolling interest for fiscal 2024 was -$1.06M.
- CRONOS GROUP INC. net income (loss) attributable to noncontrolling interest for fiscal 2023 was -$590.00K.
- CRONOS GROUP INC. net income (loss) attributable to noncontrolling interest for fiscal 2022 was $0.00.
| Period end | Net Income (Loss) Attributable to Noncontrolling Interest 3 month | Net Income (Loss) Attributable to Noncontrolling Interest 6 month | Net Income (Loss) Attributable to Noncontrolling Interest 9 month | Net Income (Loss) Attributable to Noncontrolling Interest 12 month |
|---|---|---|---|---|
| 2026-06-30 | $3.58M 10-Q · filed 2026-08-06 | $5.54M 10-Q · filed 2026-08-06 | $6.86M derived: sum of 3 quarters · filed 2026-08-06 | $9.22M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $1.96M 10-Q · filed 2026-05-11 | $3.28M derived: sum of 2 quarters · filed 2026-05-11 | $5.65M derived: sum of 3 quarters · filed 2026-05-11 | $6.88M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $1.32M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $3.69M derived: sum of 2 quarters · filed 2026-02-26 | $4.92M derived: sum of 3 quarters · filed 2026-08-06 | $6.52M 10-K · filed 2026-02-26 |
| 2025-09-30 | $2.36M 10-Q · filed 2025-11-06 | $3.59M derived: sum of 2 quarters · filed 2026-08-06 | $5.19M 10-Q · filed 2025-11-06 | $5.41M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $1.23M 10-Q · filed 2026-08-06 | $2.83M 10-Q · filed 2026-08-06 | $3.04M derived: sum of 3 quarters · filed 2026-08-06 | $2.02M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $1.60M 10-Q · filed 2026-05-11 | $1.81M derived: sum of 2 quarters · filed 2026-05-11 | $788.00K derived: sum of 3 quarters · filed 2026-05-11 | $786.00K derived: sum of 4 quarters · filed 2026-05-11 |
| 2024-12-31 | $212.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$813.00K derived: sum of 2 quarters · filed 2026-02-26 | -$815.00K derived: sum of 3 quarters · filed 2026-02-26 | -$1.06M 10-K · filed 2026-02-26 |
| 2024-09-30 | -$1.02M 10-Q · filed 2025-11-06 | -$1.03M derived: sum of 2 quarters · filed 2025-11-06 | -$1.27M 10-Q · filed 2025-11-06 | -$1.51M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | -$2.00K 10-Q · filed 2025-08-07 | -$245.00K 10-Q · filed 2025-08-07 | -$482.00K derived: sum of 3 quarters · filed 2026-02-26 | -$610.00K derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | -$243.00K 10-Q · filed 2025-05-08 | -$480.00K derived: sum of 2 quarters · filed 2026-02-26 | -$608.00K derived: sum of 3 quarters · filed 2026-02-26 | -$745.00K derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | -$237.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$365.00K derived: sum of 2 quarters · filed 2026-02-26 | -$502.00K derived: sum of 3 quarters · filed 2026-02-26 | -$590.00K 10-K · filed 2026-02-26 |
| 2023-09-30 | -$128.00K 10-Q · filed 2024-11-12 | -$265.00K derived: sum of 2 quarters · filed 2024-11-12 | -$353.00K 10-Q · filed 2024-11-12 | -$326.00K derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | -$137.00K 10-Q · filed 2024-08-08 | -$225.00K 10-Q · filed 2024-08-08 | -$198.00K derived: sum of 3 quarters · filed 2025-02-27 | -$93.00K derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | -$88.00K 10-Q · filed 2024-05-09 | -$61.00K derived: sum of 2 quarters · filed 2025-02-27 | $44.00K derived: sum of 3 quarters · filed 2025-02-27 | -$73.00K derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | $27.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $132.00K derived: sum of 2 quarters · filed 2025-02-27 | $15.00K derived: sum of 3 quarters · filed 2025-02-27 | $0.00 10-K · filed 2025-02-27 |
| 2022-09-30 | $105.00K 10-Q · filed 2023-11-08 | -$12.00K derived: sum of 2 quarters · filed 2023-11-08 | -$27.00K 10-Q · filed 2023-11-08 | -$282.00K derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-06-30 | -$117.00K 10-Q · filed 2023-08-08 | -$132.00K 10-Q · filed 2023-08-08 | -$387.00K derived: sum of 3 quarters · filed 2024-02-29 | -$637.00K derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-03-31 | -$15.00K 10-Q · filed 2023-05-09 | -$270.00K derived: sum of 2 quarters · filed 2024-02-29 | -$520.00K derived: sum of 3 quarters · filed 2024-02-29 | -$799.00K derived: sum of 4 quarters · filed 2024-02-29 |
| 2021-12-31 | -$255.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | -$505.00K derived: sum of 2 quarters · filed 2024-02-29 | -$784.00K derived: sum of 3 quarters · filed 2024-02-29 | -$1.10M 10-K · filed 2024-02-29 |
| 2021-09-30 | -$250.00K 10-Q · filed 2022-11-07 | -$529.00K derived: sum of 2 quarters · filed 2022-11-07 | -$842.00K 10-Q · filed 2022-11-07 | -$1.32M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-06-30 | -$279.00K 10-Q · filed 2022-08-09 | -$592.00K 10-Q · filed 2022-08-09 | -$1.07M derived: sum of 3 quarters · filed 2023-02-28 | -$1.64M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-03-31 | -$313.00K 10-Q · filed 2022-05-10 | -$792.00K derived: sum of 2 quarters · filed 2023-02-28 | -$1.36M derived: sum of 3 quarters · filed 2023-02-28 | -$2.09M derived: sum of 4 quarters · filed 2023-02-28 |
| 2020-12-31 | -$479.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | -$1.05M derived: sum of 2 quarters · filed 2023-02-28 | -$1.77M derived: sum of 3 quarters · filed 2023-02-28 | -$2.13M 10-K · filed 2023-02-28 |
| 2020-09-30 | -$569.00K 10-Q · filed 2022-02-18 | -$1.29M derived: sum of 2 quarters · filed 2022-02-18 | -$1.65M 10-Q · filed 2022-02-18 | -$2.09M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-06-30 | -$726.00K 10-Q/A · filed 2022-02-18 | -$1.08M 10-Q/A · filed 2022-02-18 | -$1.52M derived: sum of 3 quarters · filed 2022-03-01 | -$1.80M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-03-31 | -$359.00K 10-Q · filed 2021-05-07 | -$794.00K derived: sum of 2 quarters · filed 2022-03-01 | -$1.08M derived: sum of 3 quarters · filed 2022-03-01 | -$1.19M derived: sum of 4 quarters · filed 2022-03-01 |
| 2019-12-31 | -$435.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | -$717.00K derived: sum of 2 quarters · filed 2022-03-01 | -$828.00K derived: sum of 3 quarters · filed 2022-03-01 | -$932.00K 10-K · filed 2022-03-01 |
| 2019-09-30 | -$282.00K 10-Q · filed 2020-11-05 | -$393.00K derived: sum of 2 quarters · filed 2020-11-05 | -$497.00K 10-Q · filed 2020-11-05 | |
| 2019-06-30 | -$111.00K 10-Q · filed 2020-08-06 | -$214.00K 10-Q · filed 2020-08-06 | ||
| 2019-03-31 | -$103.00K 10-Q · filed 2020-05-08 | |||
| 2018-12-31 | -$181.00K 10-K · filed 2021-02-26 | |||
| 2017-12-31 | $0.00 10-K/A · filed 2020-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |